LumineticsCore is the first ever FDA-approved autonomous AI system for detecting diabetic retinopathy and macular edema. The technology improves access to eye exams and follow-up care for people living with diabetes.
LumineticsCore is the first ever FDA-approved autonomous AI system for detecting diabetic retinopathy and macular edema. The technology improves access to eye exams and follow-up care for people living with diabetes.
OCHIN, Inc.
PO Box 5426
Portland, OR 97228-5426
(503) 943-2500
OCHIN Connections is a monthly newsletter featuring the latest OCHIN news and perspectives supporting our mission to drive health equity.